•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

S04370 Summary:

BILL NOS04370
 
SAME ASSAME AS A07245
 
SPONSORBIAGGI
 
COSPNSRBROOKS, BROUK, COMRIE, GAUGHRAN, HOYLMAN, LIU, MAY, MYRIE, RAMOS
 
MLTSPNSR
 
Add Art 2-A Title IV §§282 & 283, Pub Health L
 
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, is to be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filers product for any period of time.
Go to top